期刊
SCIENCE
卷 334, 期 6062, 页码 1573-1577出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1208347
关键词
-
资金
- Ligue Nationale contre le Cancer (Equipes labelisees)
- Agence Nationale pour la Recherche (ANR)
- European Commission
- Fondation pour la Recherche Medicale (FRM)
- Fondation Bettencourt-Schueller Institut National du Cancer (INCa)
- Canceropole Ile-de-France
- LabEx OncoImmunology
- Association pour la Recherche sur le Cancer
- Italian Association for Cancer Research (AIRC)
- La Ligue Nationale contre le Cancer
- China Scholarship Council
- Higher Education Commission of Pakistan
- Fondation de France
Antineoplastic chemotherapies are particularly efficient when they elicit immunogenic cell death, thus provoking an anticancer immune response. Here we demonstrate that autophagy, which is often disabled in cancer, is dispensable for chemotherapy-induced cell death but required for its immunogenicity. In response to chemotherapy, autophagy-competent, but not autophagy-deficient, cancers attracted dendritic cells and T lymphocytes into the tumor bed. Suppression of autophagy inhibited the release of adenosine triphosphate (ATP) from dying tumor cells. Conversely, inhibition of extracellular ATP-degrading enzymes increased pericellular ATP in autophagy-deficient tumors, reestablished the recruitment of immune cells, and restored chemotherapeutic responses but only in immunocompetent hosts. Thus, autophagy is essential for the immunogenic release of ATP from dying cells, and increased extracellular ATP concentrations improve the efficacy of antineoplastic chemotherapies when autophagy is disabled.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据